A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.

NCT00437489 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
49
Enrollment
INDUSTRY
Sponsor class

Stopped This protocol was terminated not for safety reasons, but because Pfizer decided to return the worldwide rights for Exubera to Nektar, on 18 October 2007.

Conditions

Interventions

Sponsor

Pfizer